Yolanda Rosi Helfrich, M.D.

Assistant Professor, Department of Dermatology

Selected Publications

1. Rosi YL, Lowe L, and Kang S. Treatment of Hidradenitis Suppurativa with Infliximab in a Patient with Crohn's Disease. Journal of Dermatologic Treatment 2005; 16: 58-62.
2. Orringer JS, Helfrich YR, Hamilton T, et al. Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. Journal of the American Academy of Dermatology 2006; 54(3); 416-419.Orringer JS, Kang S, Maier L, Johnson TM, Sachs DL, Karimipour DJ, Helfrich YR, Hamilton T, Voorhees JJ. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris. Journal of the American Academy of Dermatology 2007; 56(3):432-8.
3. Schauber, J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Helfrich YR, Kang S, Elaliah HZ, Zugel U, Bikel DD, Modlin RL, Gallo RL. Injury enhances TLR2 function and cathelicidin expression through a Vitamin D dependent mechanism. Journal of Clinical Investigation 2007 ;117(3):803-811.
4. Helfrich YR, Kang S, Hamilton TA, Voorhees JJ. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study. British Journal of Dermatology 2007; 157:369-374.
5. Helfrich YR, Sachs DL, Kang S. Topical Vitamin D3 in Comprehensive Dermatologic Drug Therapy, 2nd edition, Stephen E. Wolverton, MD ed., Elsevier, Philadelphia, 2007.
6. Simon NS, Fullen DR, Helfrich YR. "Gooseflesh-like" lesions and hypohidrosis. (In press: Archives of Dermatology, 2007)
7. Skandamis G, Frohm M, Fullen DR, Helfrich YR. Extensive flaccid bullae with milia. (In press: Archives of Dermatology, 2007)